455 related articles for article (PubMed ID: 28389626)
1. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
[TBL] [Abstract][Full Text] [Related]
2. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
3. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival.
Fleming CA; Mohan HM; O'Leary DP; Corrigan M; Redmond HP
J Gastrointest Cancer; 2023 Mar; 54(1):247-258. PubMed ID: 35239102
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics and detection of colorectal cancer in humans: a systematic review.
Wang H; Tso VK; Slupsky CM; Fedorak RN
Future Oncol; 2010 Sep; 6(9):1395-406. PubMed ID: 20919825
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature.
Turkoglu O; Zeb A; Graham S; Szyperski T; Szender JB; Odunsi K; Bahado-Singh R
Metabolomics; 2016 Apr; 12(4):. PubMed ID: 28819352
[TBL] [Abstract][Full Text] [Related]
8.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
9. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
[TBL] [Abstract][Full Text] [Related]
10. Metabolic phenotyping to monitor chronic enteritis canceration.
Zhang F; Li C; Deng K; Wang Z; Zhao W; Yang K; Yang C; Rong Z; Cao L; Lu Y; Huang Y; Han P; Li K
Metabolomics; 2020 Feb; 16(3):29. PubMed ID: 32095917
[TBL] [Abstract][Full Text] [Related]
11. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
12. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y; Xie G; Jia W
J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Detection Using Targeted LC-MS Metabolic Profiling.
Djukovic D; Zhang J; Raftery D
Methods Mol Biol; 2018; 1765():229-240. PubMed ID: 29589312
[TBL] [Abstract][Full Text] [Related]
14. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
15. New trends in molecular and cellular biomarker discovery for colorectal cancer.
Aghagolzadeh P; Radpour R
World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
[TBL] [Abstract][Full Text] [Related]
16. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
17. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
18. Correlations between TBL1XR1 and recurrence of colorectal cancer.
Liu H; Xu Y; Zhang Q; Li K; Wang D; Li S; Ning S; Yang H; Shi W; Liu Z; Chen Y
Sci Rep; 2017 Mar; 7():44275. PubMed ID: 28295012
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics reveals that distant recurrence-associated protein R-Ras and Transgelin predict post-surgical survival in patients with Stage III colorectal cancer.
Xu L; Gao Y; Chen Y; Xiao Y; He Q; Qiu H; Ge W
Oncotarget; 2016 Jul; 7(28):43868-43893. PubMed ID: 27270312
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer.
Takahashi H; Ishikawa T; Ishiguro M; Okazaki S; Mogushi K; Kobayashi H; Iida S; Mizushima H; Tanaka H; Uetake H; Sugihara K
BMC Cancer; 2015 Oct; 15():794. PubMed ID: 26499327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]